For more info visit www.newsinfusion.com GARDASIL Now Approved for Use in both Males and Females in the U.S. GARDASIL is not recommended for use in pregnant women.The most common adverse reaction was headache. Common adverse reactions that were observed among recipients of GARDASIL at a frequency of at least 1.0 percent and greater than placebo were: fever, nausea, dizziness; and injection-site pain, swelling, erythema, pruritus and bruising. The Prescribing Information and Patient Product Information for GARDASIL is attached and available at: http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdfhttp://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_ppi.pdf
Genre: Entertainment
by: newsinfusion
For more info visit www.newsinfusion.comWHITEHOUSE STATION, N.J., Aug. 18, 2009 – Merck is proud to have introduced GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], the worlds first cervical cancer vaccine, a vaccine that can also help to prevent vulvar and vaginal cancers and genital warts caused by HPV types 6, 11, 16 and 18. The paper published in JAMA on Aug. 19 by the Centers for Disease Control and Prevention (CDC) is another important milestone in the medical communitys ongoing effort to monitor the safety of vaccines, including GARDASIL. We are pleased that the study published by JAMA today further reinforces the safety profile of GARDASIL. We welcome continued study and discussion about the safety of this important vaccine, said Richard M. Haupt, M.D., MPH, pediatrician and head of the clinical program for GARDASIL. Our children, our parents, our spouses and we, ourselves, are vaccinated with the same vaccines that we distribute to the ...
September 12, 2008 – The U.S. Food and Drug Administration today announced the approval of the vaccine GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26. These two HPV types cause 70 percent of cervical cancers, and are known to also cause some vulvar and vaginal cancers, but the percentages are not well defined.
Being involved in http://www.pozgroup.com makes some aspects of dating easier for people with STD's. Your condition is known up-front, your partner can offer you support based upon personal experience. You don't have the worry of infecting someone th
Genre: Illusion
by: love8video
